These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E. J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776 [Abstract] [Full Text] [Related]
6. Stimulation of postsynaptic 5-HT1A receptors is responsible for the anticonflict effect of ipsapirone in rats. Przegalinski E, Chojnacka-Wojcik E, Filip M. J Pharm Pharmacol; 1992 Sep; 44(9):780-2. PubMed ID: 1360535 [Abstract] [Full Text] [Related]
7. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems. Wierońska JM, Stachowicz K, Pałucha-Poniewiera A, Acher F, Brański P, Pilc A. Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068 [Abstract] [Full Text] [Related]
12. Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats. Chojnacka-Wójcik E, Przegaliński E. Neuropharmacology; 1991 Jul; 30(7):703-9. PubMed ID: 1681448 [Abstract] [Full Text] [Related]
14. The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists. Przegaliński E, Filip M, Chojnacka-Wójcik E, Tatarczyńska E. Pharmacol Biochem Behav; 1994 Apr; 47(4):873-8. PubMed ID: 7913223 [Abstract] [Full Text] [Related]
15. Anticonflict effect of the glycineB receptor partial agonist, D-cycloserine, in rats. Pharmacological analysis. Klodzińska A, Chojnacka-Wójcik E. Psychopharmacology (Berl); 2000 Oct; 152(2):224-8. PubMed ID: 11057527 [Abstract] [Full Text] [Related]
16. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Stachowicz K, Kłodzińska A, Palucha-Poniewiera A, Schann S, Neuville P, Pilc A. Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634 [Abstract] [Full Text] [Related]
17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M. J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550 [Abstract] [Full Text] [Related]
18. Early-life blockade of 5-HT(1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity. Vinkers CH, Oosting RS, van Bogaert MJ, Olivier B, Groenink L. Biol Psychiatry; 2010 Feb 15; 67(4):309-16. PubMed ID: 19811773 [Abstract] [Full Text] [Related]
19. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system. Khawaja XZ, Smith DL, Nawoschik SP, Zhang J, Dunlop J, Dilks DW, Olsen M, Schechter LE. J Neurochem; 2006 Jul 15; 98(1):134-45. PubMed ID: 16805803 [Abstract] [Full Text] [Related]
20. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Savić MM, Obradović DI, Ugresić ND, Cook JM, Sarma PV, Bokonjić DR. Psychopharmacology (Berl); 2005 Jul 15; 180(3):455-65. PubMed ID: 15719222 [Abstract] [Full Text] [Related] Page: [Next] [New Search]